Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury

Clinical trial NCT05507437 · COMPLETED

Trial details

NCT number: NCT05507437
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury Due to Sepsis

Start date: 2022-11-22
Primary completion: 2024-04-25
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.